They certainly keep creating new milestones and inflection points. The conference call revealed no sense that they understand their role in the utter destruction they have reaped. I am left to keep holding because I believed in the tech. I just didn't realize it was going to be an exercise in research funded by us with no value created. So many examples of others who were able to leverage their tech into deals means that their plan has been a failure and I don't see how it changes by going after one of the most difficult targets to treat. Painful lesson. The moderated example of Mesoblast highlighting their data serves as an example of how they could create value. Either the data they have sucks or they have a deal and are holding the info for now on TT data. The later is all I am left to hope for.
BLT Price at posting:
12.0¢ Sentiment: None Disclosure: Held
